Loss Per Common Share

6 Months Ended

Jun. 30, 2023

The following table sets forth the computation of basic and diluted earnings per share available for common stockholders (in thousands, except per share data):


	For the Three Months Ended June 30,				For the Six Months Ended June 30,
	2023		2022		2023		2022
Net loss attributable to common shareholders of Evolent Health, Inc.	$	(41,411)	$	(4,588)	$	(67,669)	$	(9,938)

Weighted-average common shares outstanding - basic and diluted	111,278		90,071		109,540		89,792





Loss per common share

Basic and diluted	$	(0.37)	$	(0.05)	$	(0.62)	$	(0.11)

Basic net loss per common share is calculated using the weighted average number of common shares outstanding during the period. Diluted net earnings per common share, if any, gives effect to diluted stock options (calculated based on the treasury stock method), shares issuable upon debt conversion (calculated using an as-if converted method).

Anti-dilutive shares excluded from the calculation of weighted-average common shares presented above are presented below (in thousands):


	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2023	2022	2023	2022
Restricted stock units ("RSUs"), performance-based RSUs (“PSUs”) and leveraged stock units ("LSUs")	1,073	1,642	1,505	1,817
Stock options	976	1,852	1,106	1,807
Series A Preferred Stock	4,375	—	4,375	—
Convertible senior notes	6,188	11,582	6,188	11,582
Total	12,612	15,076	13,174	15,206